Possible risk of skin reaction with DPP-4 inhibitors

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1688卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41640-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[1] DPP-4 inhibitors increase risk of cholecystitis
Reactions Weekly, 2022, 1914 (1) : 7 - 7
[2] Risk of heart failure with DPP-4 inhibitors
Reactions Weekly, 2017, 1658 (1) : 5 - 5
[3] DPP-4 inhibitors
Ahren, Bo
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) : 517 - 533
[4] DPP-4 inhibitors and risk of heart failure EXAMINEd
Standl, Eberhard
Schnell, Oliver
LANCET, 2015, 385 (9982): : 2022 - 2024
[5] Increased risk of bullous pemphigoid with DPP-4 inhibitors
Reactions Weekly, 2018, 1717 (1) : 6 - 6
[6] Sulfonylureas + DPP-4 inhibitors: increased hypoglycaemia risk
Reactions Weekly, 2016, 1601 (1) : 11 - 11
[7] No risk of GI obstruction with DPP-4 inhibitors (gliptins)
Reactions Weekly, 2016, 1629 (1) : 4 - 4
[8] Hypoglycaemia risk with dual use of DPP-4 inhibitors and sulphonylureas
David Holmes
Nature Reviews Endocrinology, 2016, 12 (7) : 374 - 374
[9] Some DPP-4 inhibitors may increase risk of angioedema
Reactions Weekly, 2022, 1919 (1) : 12 - 12
[10] No increased heart failure risk is reported with DPP-4 inhibitors
Wise, Jacqui
BMJ-BRITISH MEDICAL JOURNAL, 2016, 353

← 1 2 3 4 5 →